Eli Lilly's Retatrutide Shows Promise in Phase III, Analysts Concerned About Side Effects | Retatrutide News

Eli Lilly's Retatrutide has completed a Phase III trial, showing promise but causing concern over side effects. This highlights both its potential effic...
Clinical Trials · November 3, 2026